{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:11:05Z","timestamp":1788480665737,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Cardiovasc. Transl. Res."],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s12265-025-10679-y","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T13:58:32Z","timestamp":1756303112000},"page":"1371-1382","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diammonium Glycyrrhizinate Alleviated Myocardial Fibrosis Induced by Isoprenaline Via Modulation of STAT\/Smad3 Pathway"],"prefix":"10.1007","volume":"18","author":[{"given":"Qiaofeng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suqin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangzhu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6029-6251","authenticated-orcid":false,"given":"Mincai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"10679_CR1","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41569-020-00504-1","volume":"18","author":"B Lopez","year":"2021","unstructured":"Lopez B, Ravassa S, Moreno MU, Jose GS, Beaumont J, Gonzalez A, Diez J. Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches. Nat Rev Cardiol. 2021;18:479\u201398. https:\/\/doi.org\/10.1038\/s41569-020-00504-1.","journal-title":"Nat Rev Cardiol."},{"key":"10679_CR2","doi-asserted-by":"publisher","unstructured":"Sygitowicz G, Maciejak-Jastrzebska A, Sitkiewicz D. A review of the molecular mechanisms underlying cardiac fibrosis and atrial fibrillation. J Clin Med. 2021;10. https:\/\/doi.org\/10.3390\/jcm10194430","DOI":"10.3390\/jcm10194430"},{"key":"10679_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1146\/annurev-physiol-021119-034527","volume":"82","author":"MD Tallquist","year":"2020","unstructured":"Tallquist MD. Cardiac fibroblast diversity. Annu Rev Physiol. 2020;82:63\u201378. https:\/\/doi.org\/10.1146\/annurev-physiol-021119-034527.","journal-title":"Annu Rev Physiol"},{"key":"10679_CR4","doi-asserted-by":"publisher","unstructured":"Liu M, Lopez de Juan Abad B, Cheng K. Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies. Adv Drug Deliv Rev. 2021;173:504\u201319. https:\/\/doi.org\/10.1016\/j.addr.2021.03.021","DOI":"10.1016\/j.addr.2021.03.021"},{"key":"10679_CR5","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.ijcard.2012.11.067","volume":"168","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Elsik M, Edgley AJ, Cox AJ, Kompa AR, Wang B, Tan CY, Khong FL, Stapleton DI, Zammit S, Williams SJ, Gilbert RE, Krum H, Kelly DJ. A new anti-fibrotic drug attenuates cardiac remodeling and systolic dysfunction following experimental myocardial infarction. Int J Cardiol. 2013;168:1174\u201385. https:\/\/doi.org\/10.1016\/j.ijcard.2012.11.067.","journal-title":"Int J Cardiol."},{"key":"10679_CR6","doi-asserted-by":"publisher","first-page":"1092148","DOI":"10.3389\/fphar.2023.1092148","volume":"14","author":"C Li","year":"2023","unstructured":"Li C, Meng X, Wang L, Dai X. Mechanism of action of non-coding RNAs and traditional Chinese medicine in myocardial fibrosis: Focus on the TGF-beta\/Smad signaling pathway. Front Pharmacol. 2023;14:1092148. https:\/\/doi.org\/10.3389\/fphar.2023.1092148.","journal-title":"Front Pharmacol."},{"key":"10679_CR7","doi-asserted-by":"publisher","first-page":"100628","DOI":"10.1016\/j.jhepr.2022.100628","volume":"5","author":"J Jiao","year":"2023","unstructured":"Jiao J, Sanchez JI, Saldarriaga OA, Solis LM, Tweardy DJ, Maru DM, Stevenson HL, Beretta L. Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver disease. JHEP Rep. 2023;5:100628. https:\/\/doi.org\/10.1016\/j.jhepr.2022.100628.","journal-title":"JHEP Rep."},{"key":"10679_CR8","doi-asserted-by":"publisher","first-page":"5224","DOI":"10.1111\/jcmm.15175","volume":"24","author":"S Xu","year":"2020","unstructured":"Xu S, Mao Y, Wu J, Feng J, Li J, Wu L, Yu Q, Zhou Y, Zhang J, Chen J, Ji J, Chen K, Wang F, Dai W, Fan X, Guo C. TGF-beta\/Smad and JAK\/STAT pathways are involved in the anti-fibrotic effects of propylene glycol alginate sodium sulphate on hepatic fibrosis. J Cell Mol Med. 2020;24:5224\u201337. https:\/\/doi.org\/10.1111\/jcmm.15175.","journal-title":"J Cell Mol Med."},{"key":"10679_CR9","doi-asserted-by":"publisher","first-page":"796590","DOI":"10.3389\/fphar.2021.796590","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Hou H, Wang X, Dai X, Zhang W, Tang Q, Dong Y, Yan C, Wang B, Li Z, Cao H. Diammonium glycyrrhizinate ameliorates obesity through modulation of gut microbiota-conjugated BAs-FXR signaling. Front Pharmacol. 2021;12:796590. https:\/\/doi.org\/10.3389\/fphar.2021.796590.","journal-title":"Front Pharmacol"},{"key":"10679_CR10","doi-asserted-by":"publisher","unstructured":"Zuo J, Meng T, Wang Y, Tang W. A review of the antiviral activities of glycyrrhizic acid, glycyrrhetinic acid and glycyrrhetinic acid monoglucuronide. Pharmaceuticals (Basel). 2023;16. https:\/\/doi.org\/10.3390\/ph16050641","DOI":"10.3390\/ph16050641"},{"key":"10679_CR11","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1002\/ptr.6178","volume":"32","author":"G Pastorino","year":"2018","unstructured":"Pastorino G, Cornara L, Soares S, Rodrigues F, Oliveira M. Liquorice (Glycyrrhiza glabra): A phytochemical and pharmacological review. Phytother Res. 2018;32:2323\u201339. https:\/\/doi.org\/10.1002\/ptr.6178.","journal-title":"Phytother Res."},{"key":"10679_CR12","doi-asserted-by":"publisher","unstructured":"Yu S, Yu J, Sun F, Zhang X, Sheng W, Liu K, Li X, Li W. Diammonium glycyrrhizinate injection promotes zebrafish angiogenesis through the mTOR\/HIF-1 signaling pathway. BioRxiv. 2025;2025.02.19.639026. https:\/\/doi.org\/10.1101\/2025.02.19.639026","DOI":"10.1101\/2025.02.19.639026"},{"key":"10679_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/cns.12043","volume":"19","author":"H Zhao","year":"2013","unstructured":"Zhao H, Wang SL, Qian L, Jin JL, Li H, Xu Y, Zhu XL. Diammonium glycyrrhizinate attenuates Abeta(1\u201342) -induced neuroinflammation and regulates MAPK and NF-kappaB pathways in vitro and in vivo. CNS Neurosci Ther. 2013;19:117\u201324. https:\/\/doi.org\/10.1111\/cns.12043.","journal-title":"CNS Neurosci Ther"},{"key":"10679_CR14","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1002\/ptr.6152","volume":"32","author":"P Allawadhi","year":"2018","unstructured":"Allawadhi P, Khurana A, Sayed N, Kumari P, Godugu C. Isoproterenol-induced cardiac ischemia and fibrosis: Plant-based approaches for intervention. Phytother Res. 2018;32:1908\u201332. https:\/\/doi.org\/10.1002\/ptr.6152.","journal-title":"Phytother Res."},{"key":"10679_CR15","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.3892\/mmr.2018.9423","volume":"18","author":"Y Sun","year":"2018","unstructured":"Sun Y, Zhang Y, Chi P. Pirfenidone suppresses TGF-beta1-induced human intestinal fibroblasts activities by regulating proliferation and apoptosis via the inhibition of the Smad and PI3K\/AKT signaling pathway. Mol Med Rep. 2018;18:3907\u201313. https:\/\/doi.org\/10.3892\/mmr.2018.9423.","journal-title":"Mol Med Rep"},{"key":"10679_CR16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12931-019-1171-2","volume":"20","author":"TN Vu","year":"2019","unstructured":"Vu TN, Chen X, Foda HD, Smaldone GC, Hasaneen NA. Interferon-gamma enhances the antifibrotic effects of pirfenidone by attenuating IPF lung fibroblast activation and differentiation. Respir Res. 2019;20:206. https:\/\/doi.org\/10.1186\/s12931-019-1171-2.","journal-title":"Respir Res"},{"key":"10679_CR17","doi-asserted-by":"publisher","first-page":"734","DOI":"10.7150\/ijms.43238","volume":"17","author":"Y Tao","year":"2020","unstructured":"Tao Y, Chen Q, Zhao C, Yang X, Cun Q, Yang W, Zhang Y, Zhu Y, Zhong H. The in vitro anti-fibrotic effect of Pirfenidone on human pterygium fibroblasts is associated with down-regulation of autocrine TGF-beta and MMP-1. Int J Med Sci. 2020;17:734\u201344. https:\/\/doi.org\/10.7150\/ijms.43238.","journal-title":"Int J Med Sci."},{"key":"10679_CR18","doi-asserted-by":"publisher","first-page":"104694","DOI":"10.1016\/j.phrs.2020.104694","volume":"155","author":"A Aimo","year":"2020","unstructured":"Aimo A, Cerbai E, Bartolucci G, Adamo L, Barison A, Lo Surdo G, Biagini S, Passino C, Emdin M. Pirfenidone is a cardioprotective drug: Mechanisms of action and preclinical evidence. Pharmacol Res. 2020;155:104694. https:\/\/doi.org\/10.1016\/j.phrs.2020.104694.","journal-title":"Pharmacol Res."},{"key":"10679_CR19","doi-asserted-by":"publisher","unstructured":"Heo JY, Do JY, Lho Y, Kim AY, Kim SW, Kang SH. TGF-beta1 receptor inhibitor SB525334 attenuates the epithelial to mesenchymal transition of peritoneal mesothelial cells via the TGF-beta1 signaling pathway. Biomedicines. 2021; 9. https:\/\/doi.org\/10.3390\/biomedicines9070839","DOI":"10.3390\/biomedicines9070839"},{"key":"10679_CR20","doi-asserted-by":"publisher","first-page":"173438","DOI":"10.1016\/j.ejphar.2020.173438","volume":"887","author":"CL Braga","year":"2020","unstructured":"Braga CL, Felix NS, Teixeira DE, Vieira JB, Silva-Aguiar RP, Bose RM, Antunes MA, Rocha NDN, Caruso-Neves C, Cruz FF, Rocco PRM, Silva PL. Niclosamide attenuates lung vascular remodeling in experimental pulmonary arterial hypertension. Eur J Pharmacol. 2020;887:173438. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173438.","journal-title":"Eur J Pharmacol"},{"key":"10679_CR21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00011-021-01533-3","volume":"71","author":"YB Huo","year":"2022","unstructured":"Huo YB, Gao X, Peng Q, Nie Q, Bi W. Dihydroartemisinin alleviates AngII-induced vascular smooth muscle cell proliferation and inflammatory response by blocking the FTO\/NR4A3 axis. Inflamm Res. 2022;71:243\u201353. https:\/\/doi.org\/10.1007\/s00011-021-01533-3.","journal-title":"Inflamm Res"},{"key":"10679_CR22","doi-asserted-by":"publisher","first-page":"114","DOI":"10.22038\/ijbms.2022.67908.14848","volume":"26","author":"S Yanan","year":"2023","unstructured":"Yanan S, Bohan L, Shuaifeng S, Wendan T, Ma Z, Wei L. Inhibition of Mogroside IIIE on isoproterenol-induced myocardial fibrosis through the TLR4\/MyD88\/NF-\u03baB signaling pathway. Iran J Basic Med Sci. 2023;26:114\u201320. https:\/\/doi.org\/10.22038\/ijbms.2022.67908.14848.","journal-title":"Iran J Basic Med Sci."},{"key":"10679_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.fct.2014.08.009","volume":"73","author":"J Jin","year":"2014","unstructured":"Jin J, Xiong T, Hou X, Sun X, Liao J, Huang Z, Huang M, Zhao Z. Role of Nrf2 activation and NF-\u03baB inhibition in valproic acid induced hepatotoxicity and in diammonium glycyrrhizinate induced protection in mice. Food Chem Toxicol. 2014;73:95\u2013104. https:\/\/doi.org\/10.1016\/j.fct.2014.08.009.","journal-title":"Food Chem Toxicol"},{"key":"10679_CR24","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1007\/s12265-021-10192-y","volume":"15","author":"K Wang","year":"2022","unstructured":"Wang K, Li Z, Sun Y, Liu X, Ma W, Ding Y, Hong J, Qian L, Xu D. Dapagliflozin improves cardiac function, remodeling, myocardial apoptosis, and inflammatory cytokines in mice with myocardial infarction. J Cardiovasc Transl Res. 2022;15:786\u201396. https:\/\/doi.org\/10.1007\/s12265-021-10192-y.","journal-title":"J Cardiovasc Transl Res"},{"key":"10679_CR25","doi-asserted-by":"publisher","first-page":"2224607","DOI":"10.1080\/13510002.2023.2224607","volume":"28","author":"S Mi","year":"2023","unstructured":"Mi S, Huang F, Jiao M, Qian Z, Han M, Miao Z, Zhan H. Inhibition of MEG3 ameliorates cardiomyocyte apoptosis and autophagy by regulating the expression of miRNA-129\u20135p in a mouse model of heart failure. Redox Rep. 2023;28:2224607. https:\/\/doi.org\/10.1080\/13510002.2023.2224607.","journal-title":"Redox Rep"},{"key":"10679_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.arcmed.2019.07.004","volume":"50","author":"M Li","year":"2019","unstructured":"Li M, Wang Z, Xia H, Yu L, Hu Z. Vildagliptin and G-CSF improved angiogenesis and survival after acute myocardial infarction. Arch Med Res. 2019;50:133\u201341. https:\/\/doi.org\/10.1016\/j.arcmed.2019.07.004.","journal-title":"Arch Med Res"},{"key":"10679_CR27","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1055\/s-0042-1743145","volume":"16","author":"R Juengsomjit","year":"2022","unstructured":"Juengsomjit R, Meesakul O, Arayapisit T, Larbcharoensub N, Janebodin K. Polarized microscopic analysis of picrosirius red stained salivary gland pathologies: an observational study. Eur J Dent. 2022;16:930\u20137. https:\/\/doi.org\/10.1055\/s-0042-1743145.","journal-title":"Eur J Dent"},{"key":"10679_CR28","doi-asserted-by":"publisher","first-page":"e82743","DOI":"10.1371\/journal.pone.0082743","volume":"8","author":"M Li","year":"2013","unstructured":"Li M, Li S, Yu L, Wu J, She T, Gan Y, Hu Z, Liao W, Xia H. Bone mesenchymal stem cells contributed to the neointimal formation after arterial injury. PLoS One. 2013;8:e82743. https:\/\/doi.org\/10.1371\/journal.pone.0082743.","journal-title":"PLoS One."},{"key":"10679_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/ehf2.14571","volume":"11","author":"Y Higuchi","year":"2024","unstructured":"Higuchi Y, Ogata T, Nakanishi N, Nishi M, Tsuji Y, Tomita S, Conway SJ, Matoba S. Cavin-2 promotes fibroblast-to-myofibroblast trans-differentiation and aggravates cardiac fibrosis. ESC Heart Fail. 2024;11:167\u201378. https:\/\/doi.org\/10.1002\/ehf2.14571.","journal-title":"ESC Heart Fail."},{"key":"10679_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s00018-023-04699-7","volume":"80","author":"CX Ma","year":"2023","unstructured":"Ma CX, Wei ZR, Sun T, Yang MH, Sun YQ, Kai KL, Shi JC, Zhou MJ, Wang ZW, Chen J, Li W, Wang TQ, Zhang SF, Xue L, Zhang M, Yin Q, Zang MX. Circ-sh3rf3\/GATA-4\/miR-29a regulatory axis in fibroblast-myofibroblast differentiation and myocardial fibrosis. Cell Mol Life Sci. 2023;80:50. https:\/\/doi.org\/10.1007\/s00018-023-04699-7.","journal-title":"Cell Mol Life Sci"},{"key":"10679_CR31","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1097\/SHK.0000000000002353","volume":"61","author":"Y Meng","year":"2024","unstructured":"Meng Y, Cai X, Cong S, Sun J, Du W, Cui H, Luo L, Ma X, Wang L. Diammonium glycyrrhizinate inhibited inflammatory response and modulated serum metabolism in poly(I:C)-induced pneumonia model mice. Shock. 2024;61:905\u201314. https:\/\/doi.org\/10.1097\/SHK.0000000000002353.","journal-title":"Shock."},{"key":"10679_CR32","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/S1995-7645(14)60157-7","volume":"7","author":"WY Cai","year":"2014","unstructured":"Cai WY, Gu YY, Li AM, Cui HQ, Yao Y. Effect of alprostadil combined with Diammonium glycyrrhizinate on renal interstitial fibrosis in SD rats. Asian Pac J Trop Med. 2014;7:900\u20134. https:\/\/doi.org\/10.1016\/S1995-7645(14)60157-7.","journal-title":"Asian Pac J Trop Med"},{"key":"10679_CR33","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/jpp\/rgac030","volume":"74","author":"W Huang","year":"2022","unstructured":"Huang W, Zhou X. Anti-histamine effects of dipotassium glycyrrhizinate on lung fibroblasts, implicating its therapeutic mechanism for pulmonary fibrosis. J Pharm Pharmacol. 2022;74:1241\u201350. https:\/\/doi.org\/10.1093\/jpp\/rgac030.","journal-title":"J Pharm Pharmacol"},{"key":"10679_CR34","doi-asserted-by":"publisher","first-page":"e20190103","DOI":"10.1084\/jem.20190103","volume":"217","author":"N Frangogiannis","year":"2020","unstructured":"Frangogiannis N. Transforming growth factor-beta in tissue fibrosis. J Exp Med. 2020;217:e20190103. https:\/\/doi.org\/10.1084\/jem.20190103.","journal-title":"J Exp Med"},{"key":"10679_CR35","doi-asserted-by":"publisher","unstructured":"Wang HL, Wang L, Zhao CY, Lan HY. Role of TGF-beta signaling in beta cell proliferation and function in diabetes. Biomolecules. 2022;12. https:\/\/doi.org\/10.3390\/biom12030373","DOI":"10.3390\/biom12030373"},{"key":"10679_CR36","doi-asserted-by":"publisher","first-page":"234","DOI":"10.22088\/IJMCM.BUMS.10.4.234","volume":"10","author":"NI Hariyanto","year":"2021","unstructured":"Hariyanto NI, Yo EC, Wanandi SI. Regulation and Signaling of TGF-beta Autoinduction. Int J Mol Cell Med. 2021;10:234\u201347. https:\/\/doi.org\/10.22088\/IJMCM.BUMS.10.4.234.","journal-title":"Int J Mol Cell Med."}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-025-10679-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-025-10679-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-025-10679-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T15:11:37Z","timestamp":1763565097000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-025-10679-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10679"],"URL":"https:\/\/doi.org\/10.1007\/s12265-025-10679-y","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"assertion":[{"value":"23 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were conducted by the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH publication 86 23, revised 2011) and approved by the Institutional Animal Care and Use Committee at Hubei University of Science and Technology(approval number. 42000600050806; approval date, March 21, 2023).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}